Cell line-derived xenograft models (CDX models) are in vivo models where human-derived tumor cells are transplanted into the mice for efficacy evaluation or tumor-related research. It is one of the most frequently used in vivo models for preclinical analyses of anticancer medicines.
GemPharmatech has developed a large source of human CDX (cell derived xenograft) tumor models to support our effort in preclinical testing of novel anti-tumor therapeutics. For this purpose, these xenografts are indispensable and complementary components with our novel immunodeficient mouse models.
GemPharmatech's extensive selection of CDX cell lines, including pancreatic cancer, breast cancer, colon cancer, lung cancer, and lymphoma, can accommodate the requirements of various pharmacodynamic and efficacy investigations.